Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
US Army
Chinese Patent Office
UBS
Boehringer Ingelheim
AstraZeneca
Express Scripts
QuintilesIMS

Generated: October 19, 2018

DrugPatentWatch Database Preview

Amlodipine besylate; telmisartan - Generic Drug Details

« Back to Dashboard

What are the generic sources for amlodipine besylate; telmisartan and what is the scope of amlodipine besylate; telmisartan freedom to operate?

Amlodipine besylate; telmisartan is the generic ingredient in two branded drugs marketed by Alembic Pharms Ltd, Lupin Ltd, Mylan Pharms Inc, Torrent Pharms Ltd, and Boehringer Ingelheim, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty drug master file entries for amlodipine besylate; telmisartan. Six suppliers are listed for this compound.

Summary for amlodipine besylate; telmisartan
US Patents:0
Tradenames:2
Applicants:5
NDAs:5
Drug Master File Entries: 50
Suppliers / Packagers: 6
DailyMed Link:amlodipine besylate; telmisartan at DailyMed

US Patents and Regulatory Information for amlodipine besylate; telmisartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-004 Oct 16, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-003 Oct 16, 2009 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 205234-002 Nov 17, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 202516-001 Aug 26, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for amlodipine besylate; telmisartan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-001 Oct 16, 2009 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-002 Oct 16, 2009 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-004 Oct 16, 2009 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim TWYNSTA amlodipine besylate; telmisartan TABLET;ORAL 022401-003 Oct 16, 2009 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
US Army
Chinese Patent Office
UBS
Boehringer Ingelheim
AstraZeneca
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.